Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongtao Duan

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Frontiers in Chemistry|July 22, 2021
Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation StrategyMinghua Yuan, Yanan Chu, Yongtao Duan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 24, 2024
Movement disorders related to antidiabetic medications: a real-world pharmacovigilance studyYingjie Zhao, Lu Fei, Yongtao Duan
Molecular Neurobiology|April 23, 2025
Combining GWAS Summary Data and Proteomics Identified Potential Drug Targets in DementiaYingjie Zhao, Lu Fei, Yongtao Duan
Drug Discovery Today|August 10, 2025
Role of P2Y<sub>6</sub>R in cancer and its antagonistsXin Wang, Jiliang Zhang, Yongtao Duan, et al.
Current Topics in Medicinal Chemistry|June 17, 2020
Butterfly Structure: A Privileged Scaffold Targeting Tubulin-Colchicine Binding SiteYingge Wang, Yongfang Yao, Hai-Liang Zhu, et al.
Current Topics in Medicinal Chemistry|October 24, 2019
The Present and Future of Novel Protein Degradation TechnologyLiwen Xia, Wei Liu, Yinsen Song, et al.
Current Topics in Medicinal Chemistry|June 19, 2019
Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation AgentsYongtao Duan, Wei Liu, Liang Tian, et al.
Frontiers in Oncology|October 14, 2022
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatmentReem Altaf, Sarmad Sheraz Jadoon, Syed Aun Muhammad, et al.
Pharmacological Research|October 9, 2021
The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitorsJingtian Su, Xuan Wang, Yuwei Bai, et al.
Frontiers in Endocrinology|January 10, 2022
Association of Preadmission Metformin Use and Prognosis in Patients With Sepsis and Diabetes Mellitus: A Systematic Review and Meta-AnalysisYuanzhe Li, Huayan Zhao, Yalin Guo, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Chemistry|July 22, 2021
Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation StrategyMinghua Yuan, Yanan Chu, Yongtao Duan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 24, 2024
Movement disorders related to antidiabetic medications: a real-world pharmacovigilance studyYingjie Zhao, Lu Fei, Yongtao Duan
Molecular Neurobiology|April 23, 2025
Combining GWAS Summary Data and Proteomics Identified Potential Drug Targets in DementiaYingjie Zhao, Lu Fei, Yongtao Duan
Drug Discovery Today|August 10, 2025
Role of P2Y<sub>6</sub>R in cancer and its antagonistsXin Wang, Jiliang Zhang, Yongtao Duan, et al.
Current Topics in Medicinal Chemistry|June 17, 2020
Butterfly Structure: A Privileged Scaffold Targeting Tubulin-Colchicine Binding SiteYingge Wang, Yongfang Yao, Hai-Liang Zhu, et al.
Current Topics in Medicinal Chemistry|October 24, 2019
The Present and Future of Novel Protein Degradation TechnologyLiwen Xia, Wei Liu, Yinsen Song, et al.
Current Topics in Medicinal Chemistry|June 19, 2019
Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation AgentsYongtao Duan, Wei Liu, Liang Tian, et al.
Frontiers in Oncology|October 14, 2022
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatmentReem Altaf, Sarmad Sheraz Jadoon, Syed Aun Muhammad, et al.
Pharmacological Research|October 9, 2021
The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitorsJingtian Su, Xuan Wang, Yuwei Bai, et al.
Frontiers in Endocrinology|January 10, 2022
Association of Preadmission Metformin Use and Prognosis in Patients With Sepsis and Diabetes Mellitus: A Systematic Review and Meta-AnalysisYuanzhe Li, Huayan Zhao, Yalin Guo, et al.
Pageof 6